PharmaSGP Holding ROA

ROA

0.12

Ticker

PSG.DE

ISIN

DE000A2P4LJ5

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

In 2026, PharmaSGP Holding's return on assets (ROA) was 0.12, a 0% increase from the 0 ROA in the previous year.

PharmaSGP Holding Aktienanalyse

What does PharmaSGP Holding do? PharmaSGP Holding SE is a leading European company specializing in the marketing of over-the-counter and natural pharmaceuticals. The company was founded in 2009 and is headquartered in Gräfelfing near Munich. The history of PharmaSGP began with the vision of founder and CEO Alexander Kurz, who believed that many people were looking for natural alternatives to pharmaceuticals. Kurz founded PharmaSGP with the goal of developing natural health products that help people improve their health and well-being. PharmaSGP's business model focuses on the marketing of over-the-counter and natural pharmaceuticals through pharmacies, drugstores, and online sales. The company has a strong presence in Europe and is also expanding into other regions worldwide. PharmaSGP is divided into three divisions: Consumer Healthcare, Medical Devices, and Healthcare Services. The Consumer Healthcare division offers natural health products and dietary supplements targeting consumers. The company has developed a wide range of products specifically tailored to the needs of people at different stages of life, from pregnancy and breastfeeding to old age. In the field of medical devices, PharmaSGP focuses on the development and marketing of innovative medical devices and technologies tailored to the needs of healthcare professionals. The company has developed a range of medical devices such as medication dispensers or blood glucose meters to facilitate disease treatment. In the Healthcare Services division, the company also offers services such as medical consulting and patient management. This involves holistic patient care, offering various services to ensure effective and comprehensive treatment. PharmaSGP also has an impressive range of products covering various health areas. There are products for dietary supplementation, sleep support, pain therapy, and cold relief, to name just a few. One of PharmaSGP's most well-known products is Yokebe, a natural meal replacement that can help reduce weight. The company is committed to ensuring the quality of its products and therefore works closely with scientists and healthcare professionals to ensure that all products are based on current scientific knowledge and studies. In summary, PharmaSGP is an innovative company focused on the marketing of natural and over-the-counter pharmaceuticals. It has developed a wide range of products and services specifically tailored to the needs of consumers and healthcare professionals. The company is committed to continuously improving the quality of its products and services and works closely with scientists and healthcare professionals to ensure comprehensive patient care. PharmaSGP Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding PharmaSGP Holding's Return on Assets (ROA)

PharmaSGP Holding's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing PharmaSGP Holding's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider PharmaSGP Holding's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in PharmaSGP Holding’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about PharmaSGP Holding stock

The Return on Assets (ROA) of PharmaSGP Holding is 0.12 undefined this year.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PharmaSGP Holding

Our stock analysis for PharmaSGP Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaSGP Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.